Loading…
ALMR
Alamar Biosciences, Inc.
NASDAQ· Healthcare· Medical Devices· CUSIP 010911105
$25.28-7.80%Price as of Oct 17, 12:05 UTC · updated once a day, after the close
At a glance
Alamar Biosciences, Inc. (ALMR) is listed on NASDAQ and classified in Medical Devices, part of the Healthcare sector. It is headquartered in Fremont, United States and has 286 employees. The company is worth $1.75B. Revenue was $74.21M in fiscal 2025, up 195.2% from the year before. It reported a net loss of $29.82M. The share price is 36.2% below its 52-week high of $39.61. 4 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Israel Englander (Millennium Management), at $23.45M. In that quarter, 4 of them opened or added to the position. Over the last 30 days, company insiders sold $10.77M of its stock on the open market and bought none.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $1.75B
- P/E
- —
- Forward P/E
- —
- P/B
- 5.6x
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- -$1.20
- ROE
- —
- Profit margin
- -49.45%
- Revenue growth
- +82.10%
- Beta
- —
- 52-week high
- $39.61
- 52-week low
- $18.85
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ATECAlphatec Holdings, Inc. | $11.36 | — | — | 0.00% | -373.44% | $1.75B |
| NVCRNovoCure Ltd | $15.10 | — | 5.2x | 0.00% | -43.22% | $1.76B |
| ALHCAlignment Healthcare, Inc. | $8.43 | 44.4x | 6.6x | 0.00% | 20.04% | $1.75B |
| VIRVir Biotechnology, Inc. | $10.43 |
About the company
- 286
- Fremont, United States